Drug Survival of Interleukin (IL)‐17 and IL‐23 Inhibitors for the Treatment of Psoriasis: A Retrospective Multi‐country, Multicentric Cohort Study

MLA

Torres, Tiago, et al. Drug Survival of Interleukin (IL)‐17 and IL‐23 Inhibitors for the Treatment of Psoriasis: A Retrospective Multi‐country, Multicentric Cohort Study. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1355229565&authtype=sso&custid=ns315887.

APA

Torres, T., Puig, L., Vender, R., Yeung, J., Carrascosa, J.-M., Piaserico, S., Gisondi, P., Lynde, C., Ferreira, P., Bastos, P. M., Dauden, E., Leite, L., Valerio, J., Del Alcázar-Viladomiu, E., Rull, E. V., Llamas-Velasco, M., Pirro, F., Messina, F., Bruni, M., … Chiricozzi, A. (ORCID:0000-0002-6739-0387). (2022). Drug Survival of Interleukin (IL)‐17 and IL‐23 Inhibitors for the Treatment of Psoriasis: A Retrospective Multi‐country, Multicentric Cohort Study.

Chicago

Torres, Tiago, Lui Puig, Ron Vender, Jensen Yeung, José-Manuel Carrascosa, Stefano Piaserico, Paolo Gisondi, et al. 2022. “Drug Survival of Interleukin (IL)‐17 and IL‐23 Inhibitors for the Treatment of Psoriasis: A Retrospective Multi‐country, Multicentric Cohort Study.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1355229565&authtype=sso&custid=ns315887.